3SBIO (01530) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)
The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.
Zhitong FinanceNov 3 20:45 ET
Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.
①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.
cls.cnNov 1 08:59 ET
zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.
The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.
Zhitong FinanceOct 29 22:28 ET
The Five-year Underlying Earnings Growth at 3SBio (HKG:1530) Is Promising, but the Shareholders Are Still in the Red Over That Time
Simply Wall StOct 29 18:58 ET
Hong Kong healthcare stocks receive attention from investors again, with Trifolium Biotech surging nearly 15%.
①What is the impact of medical insurance negotiations on pharmaceutical stocks? ②What are the reasons for the rise of Tri Clover Biopharmaceutical and Yimington Corporation?
cls.cnOct 28 23:05 ET
3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution
MT NewswiresOct 24 07:26 ET

Comments

Bull X Bear

Oct 3 02:14

What would you buy in your Hong Kong portfolio?

Banks: $ABC (01288.HK)$ $BANK OF CHINA (03988.HK)$
Securities & Brokerage: $HTSC (06886.HK)$ $CMSC (06099.HK)$
Gaming Software: $NTES-S (09999.HK)$ $XD INC (02400.HK)$ $NETDRAGON (00777.HK)$
Digital Solutions: $TENCENT (00700.HK)$ $TRAVELSKY TECH (00696.HK)$ $CHINASOFT INT'L (00354.HK)$
Online Retailer: $BABA-W (09988.HK)$ $MEITUAN-W (03690.HK)$ $JD-SW (09618.HK)$
Insurer: $PING AN (02318.HK)$ $AIA (01299.HK)$ $CHINA LIFE (02628.HK)$
Telecommunication: $CHINA MOBILE (00941.HK)$ $CHINA TELECOM (00728.HK)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

13

7

Moomoo AI

Mar 17 20:08

3SBio Inc.'s lower P/E ratio is due to its forecasted growth being less than the wider market. The potential for earnings improvement may not justify a higher P/E ratio, forming a barrier for the share price.

Investors Don't See Light At End Of 3SBio Inc.'s (HKG:1530) Tunnel

1

Moomoo AI

Jan 24 01:50

Despite a recent drop, 3SBio's strong financials and high ROE could boost stock value long term. Significant earnings growth due to substantial profit reinvestment, though future growth may slow.

Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?

Moomoo AI

Dec 28, 2023 17:33

Analyst indicates that the investment risk in 3SBio is kept in check by net cash and EBIT growth. Even though managing debt could be challenging as free cash flow was only 46% of EBIT recently, the company's financials are still strong.

3SBio (HKG:1530) Seems To Use Debt Rather Sparingly

Moomoo AI

Dec 7, 2023 16:19

3SBio, with EPS growth and increased EBIT margins, is defined as a growing business. High level of insider ownership is deemed positive, aligning with shareholders' interests. Yet, the market valuation of it remains unanalysed.

3SBio (HKG:1530) Ticks All The Boxes When It Comes To Earnings Growth

01530 3SBIO

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target